Syuji Takei

Kagoshima University — Japan

Medicine · Health Sciences

34h-index4.5kcitations159works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autoimmune and Inflammatory Disorders Research(76), Rheumatoid Arthritis Research and Therapies(39), Adolescent and Pediatric Healthcare(34), Systemic Lupus Erythematosus Research(31), Inflammasome and immune disorders(22)

Publications157 total

P13-01 Caffeine intoxication due to the drug-drug interaction
Toxicology Letters·2025
Longitudinal Analysis of Somatic Mosaicism and Clonal Hematopoiesis in Cryopyrin‐Associated Periodic Syndrome
Arthritis & Rheumatology·2025· 1 cited
WITHDRAWN: Ten-year follow-up of patients with refractory systemic juvenile idiopathic arthritis after the clinical trial of tocilizumab as a first biologic disease-modifying antirheumatic drug
EULAR Rheumatology Open·2025
Correction: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study
Pediatric Rheumatology·2025· 1 citedOpen Access
Three-year safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Final analysis of an all-case postmarketing surveillance study
Modern Rheumatology·2025· 3 citedOpen Access
Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study
Pediatric Rheumatology·2025· 2 citedOpen Access
AB0517 THREE-YEAR SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN JAPAN: FINAL ANALYSIS OF A POST-MARKETING SURVEILLANCE STUDY
Annals of the Rheumatic Diseases·2024
Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance
Modern Rheumatology·2023· 8 citedOpen Access
POS0760 LONG-TERM PROGNOSTIC FOLLOW-UP OF PATIENTS WITH REFRACTORY SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS AFTER THE CLINICAL TRIAL OF TOCILIZUMAB AS A FIRST-LINE BIOLOGIC TREATMENT
Annals of the Rheumatic Diseases·2023· 1 citedOpen Access
Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
Modern Rheumatology·2022· 10 citedOpen Access
Rheumatoid factor value for determining the first biologic agent to use for non-systemic juvenile idiopathic arthritis
Modern Rheumatology·2022· 1 cited
Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases
Frontiers in Immunology·2022· 40 citedOpen Access
Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis
Frontiers in Immunology·2022· 27 citedOpen Access
Childhood Arthritis and Rheumatology Research for Dreams Come True Remission
Children·2022· 2 citedOpen Access
209 TNF-Targeting Treatment Corrects Proinflammatory Signatures of Autoinflammatory Blau Syndrome
Journal of Investigative Dermatology·2021Open Access
Clinical practice guidance for childhood-onset systemic lupus erythematosus—secondary publication
Modern Rheumatology·2021· 4 cited
Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison
RMD Open·2021· 29 citedOpen Access
Pediatric Dual-Energy X-Ray Absorptiometry in Japan: A Proposal for Shared Access to Equipment.
PubMed·2021
Anti-TNF treatment corrects IFN-γ–dependent proinflammatory signatures in Blau syndrome patient–derived macrophages
Journal of Allergy and Clinical Immunology·2021· 13 cited
Detailed analysis of Japanese patients with adenosine deaminase 2 deficiency reveals characteristic elevation of type II interferon signature and STAT1 hyperactivation
Journal of Allergy and Clinical Immunology·2021· 51 cited
page 1 of 8Next →

Frequent Co-authors

Shumpei Yokota(13), Masaaki Mori(11), Naomi Iwata(10), Tomoyuki Imagawa(9), Nobuaki Maeno(8), Hiroyuki Imanaka(8), Takuji Murata(8), Yoshiya Tanaka(7), Masayoshi Harigai(7), Tomohiro Kubota(7), Mari Miyoshi(7), Hiroaki Umebayashi(7), Minako Tomiita(7), Norihiro Nishimoto(6), Takao Koike(6), Yoshifumi Kawano(6), Shigeko Inokuma(5), Naoki Ishiguro(5), Tsutomu Takeuchi(5), Hisashi Yamanaka(5)